Efficacy and in vitro activity of gepotidacin against bacterial uropathogens, including drug-resistant phenotypes, in females with uncomplicated urinary tract infections: results from two global, pivotal, phase 3 trials (EAGLE-2 and EAGLE-3).
Saved in:
| Title: | Efficacy and in vitro activity of gepotidacin against bacterial uropathogens, including drug-resistant phenotypes, in females with uncomplicated urinary tract infections: results from two global, pivotal, phase 3 trials (EAGLE-2 and EAGLE-3). |
|---|---|
| Authors: | Scangarella-Oman NE; GSK, Collegeville, Pennsylvania, USA., Butler DL; GSK, Collegeville, Pennsylvania, USA., Breton J; GSK, Collegeville, Pennsylvania, USA., Brown D; GSK, Collegeville, Pennsylvania, USA., Kasapidis C; GSK, Collegeville, Pennsylvania, USA., Millns H; GSK, Stevenage, Hertfordshire, United Kingdom., Huang C; GSK, Collegeville, Pennsylvania, USA., Perry CR; GSK, Collegeville, Pennsylvania, USA., Sheets AJ; GSK, Collegeville, Pennsylvania, USA., Dennison J; GSK, London, United Kingdom., Janmohamed S; GSK, London, United Kingdom. |
| Source: | Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2025 Oct; Vol. 69 (10), pp. e0164024. Date of Electronic Publication: 2025 Sep 09. |
| Publication Type: | Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial |
| Journal Info: | Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1098-6596 |
|---|---|
| DOI: | 10.1128/aac.01640-24 |
